Author

Mark Lawrence Heaney

Columbia University Irving Medical CenterORCID 0000-0002-4886-9149Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adina GrunniD· 1 shared Alfred I. NeugutiD· 1 shared Allison R. RaineyiD· 1 shared Ana Isabel TergasiD· 1 shared Andrea CalifanoiD· 1 shared Andrew B. LassmaniD· 1 shared Andrew L. KungiD· 1 shared Armaan H. SiddiqueeiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Adina GrunnORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

Prabhjot Singh Mundi, Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey, Kristina C. Guillan, Armaan H. Siddiquee, Daoqi You, Ronald B. Realubit, Charles Karan, Michael Vincent Ortiz, Eugene F. Douglass, Melissa Kate Accordino, Suzanne Mistretta, , Andrea Califano

The paper validates an RNA-based platform for predicting drug sensitivity in treatment-resistant cancers using patient-derived xenograft models and multi-protein therapies.

Cancer Discovery · Apr 16, 2023Peer-reviewedSystems Biology